Table 1 Breast cancer survivors’ characteristics (n = 939)
From: Breast cancer survivors’ opinion on personalizing endocrine therapy and developing informative tools
Variables | Number of participants (%) |
|---|---|
Gender | |
Male | 6 (0.9%) |
Female | 933 (99.1%) |
Age category at the time of survey completion | |
<30 years | 7 (0.8%) |
30–39 years | 84 (9.0%) |
40–49 years | 255 (27.2%) |
50–59 years | 309 (32.9%) |
60–69 years | 227 (24.2%) |
>70 years | 57(6.1%) |
Status of endocrine therapy | |
Ongoing treatment | 629 (67.0%) |
Completed treatment | 222 (23.6%) |
Discontinued for poor tolerance | 73 (7.8%) |
Discontinued for personal reasons | 15 (1.6%) |
Duration of endocrine therapy | |
Less than 6 months | 63 (6.7%) |
Between 6 months and 1 year | 87 (9.3%) |
Between 1 and 3 years | 281 (29.9%) |
Between 3 and 5 years | 362 (38.6%) |
More than 5 years | 146 (15.6%) |
